Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth
Abstract Curcumin has been reported to exhibit anti-tumorigenic activity; however, since its precise actions remain unclear, its effects are considered to be deceptive. In the present study, we confirmed the anti-tumorigenic effects of curcumin on CML-derived leukemic cells in a xenograft model and...
Saved in:
Main Authors: | Yonika Arum Larasati, Noriko Yoneda-Kato, Ikuko Nakamae, Takashi Yokoyama, Edy Meiyanto, Jun-ya Kato |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/07f6f3b6ec8249c3a3d4c9e91b652c41 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New curcumin analog, CCA-1.1, synergistically improves the antiproliferative effect of doxorubicin against T47D breast cancer cells
by: Febri Wulandari, et al.
Published: (2020) -
Illuminating the effect of beneficial blue light and ROS-modulating enzymes in Dupuytren's disease.
by: Carina Jaekel, et al.
Published: (2021) -
Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance
by: Haohao Huang, et al.
Published: (2021) -
Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death
by: Hongzhang Deng, et al.
Published: (2020) -
Author Correction: Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death
by: Hongzhang Deng, et al.
Published: (2021)